Figure 4.
Transplanted-related mortality by 5 year periods for 4 subgroups is shown: (A) Recipients of HLA-matched related donor transplants in first CR, (B) Recipients of HLA-matched related transplants in second CR, (C) Recipients of unrelated donor transplants in first CR, and (D) Recipients of unrelated donor transplants in second CR [8]. Reprinted with permission. © 2011 American Society of Clinical Oncology. All rights reserved.